|
Vaccine Detail
VC-TetC/Tcf |
Vaccine Information |
- Vaccine Name: VC-TetC/Tcf
- Target Pathogen: Bordetella pertussis
- Target Disease: Whooping Cough
- Product Name: VC expressing B. pertussis TetC/Tcf
- Vaccine Ontology ID: VO_0004781
- Type: Recombinant vector vaccine
- Status: Research
- Host Species for Licensed Use: Baboon
- TcfA
gene engineering:
- Type: Recombinant protein preparation
- Description: An attenuated strain of Vibrio cholerae was used as a carrier for the expression of heterologous antigens such as fragment C from tetanus toxin (TetC) and tracheal colonization factor from Bordetella pertussis (Tcf) (Chen et al., 1998).
- Detailed Gene Information: Click Here.
- Vector:
- Preparation: An attenuated strain of Vibrio cholerae was used as a carrier for the expression of heterologous antigens such as fragment C from tetanus toxin (TetC) and tracheal colonization factor from Bordetella pertussis (Tcf) (Chen et al., 1998).
- Immunization Route: intranasal immunization
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000287
- Challenge Protocol: Mice were challenged with wild-type B. pertussis (Chen et al., 1998).
- Efficacy: Mice vaccinated with IEM101 expressing Tcf experienced significant reduction in bacterial colonization of their tracheas (Chen et al., 1998).
|
References |
Chen et al., 1998: Chen I, Finn TM, Yanqing L, Guoming Q, Rappuoli R, Pizza M. A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor. Infection and immunity. 1998; 66(4); 1648-1653. [PubMed: 9529093].
|
|